Janux Therapeutics (JANX) Amortizatization of Intangibles (2021 - 2026)

Janux Therapeutics (JANX) has 6 years of Amortizatization of Intangibles data on file, last reported at $2.6 million in Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $2.6 million, down 37.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (up 22.72% YoY), and the FY2025 annual result was $17.6 million, up 66.03% from the prior year.
• Amortizatization of Intangibles retreated to $2.6 million in Q1 2026 per JANX's latest filing, from $3.5 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $5.2 million in Q2 2025 and troughed at $24000.0 in Q1 2022.
• A 5-year average of $2.4 million and a median of $2.1 million in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 6891.67% in 2023, then tumbled 37.83% in 2026.
• A 5-year view of Amortizatization of Intangibles shows it stood at $1.3 million in 2022, then soared by 59.52% to $2.1 million in 2023, then jumped by 42.02% to $2.9 million in 2024, then advanced by 20.4% to $3.5 million in 2025, then declined by 25.54% to $2.6 million in 2026.
• Business Quant data shows JANX's Amortizatization of Intangibles at $2.6 million in Q1 2026, $3.5 million in Q4 2025, and $4.6 million in Q3 2025.